Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Hepatitis B vaccination at three months of age: a successful strategy?

Chiara F, Bartolucci GB, Mongillo M, Ferretto L, Nicolli A, Trevisan A.

Vaccine. 2013 Mar 25;31(13):1696-700. doi: 10.1016/j.vaccine.2013.01.046. Epub 2013 Feb 4.

PMID:
23384750
2.

Significance and anamnestic response in isolated hepatitis B core antibody-positive individuals 18 years after neonatal hepatitis B virus vaccination in Taiwan.

Su FH, Bai CH, Chu FY, Lin YS, Su CT, Yeh CC.

Vaccine. 2012 Jun 8;30(27):4034-9. doi: 10.1016/j.vaccine.2012.04.031. Epub 2012 Apr 22.

PMID:
22531558
4.

Presence of immune memory and immunity to hepatitis B virus in adults after neonatal hepatitis B vaccination.

Zhu CL, Liu P, Chen T, Ni Z, Lu LL, Huang F, Lu J, Sun Z, Qu C.

Vaccine. 2011 Oct 13;29(44):7835-41. doi: 10.1016/j.vaccine.2011.07.098. Epub 2011 Aug 2.

PMID:
21816197
5.

Hepatitis B vaccination: long-term follow-up of the immune response of preterm infants and comparison of two vaccination protocols.

Linder N, Vishne TH, Levin E, Handsher R, Fink-Kremer I, Waldman D, Levine A, Ashkenazi S, Sirota L.

Infection. 2002 Jun;30(3):136-9.

PMID:
12120937
6.

Antibody levels and immune memory 23 years after primary plasma-derived hepatitis B vaccination: results of a randomized placebo-controlled trial cohort from China where endemicity is high.

Wu Q, Zhuang GH, Wang XL, Wang LR, Li N, Zhang M.

Vaccine. 2011 Mar 9;29(12):2302-7. doi: 10.1016/j.vaccine.2011.01.025. Epub 2011 Jan 28.

PMID:
21277403
7.

Predictors of Hepatitis B Surface Antigen Titers two decades after vaccination in a cohort of students and post-graduates of the Medical School at the University of Palermo, Italy.

Verso MG, Lo Cascio N, Noto Laddeca E, Amodio E, Currieri M, Giammanco G, Ferraro D, De Grazia S, Picciotto D.

Ann Agric Environ Med. 2017 Jun 12;24(2):303-306.

PMID:
28664713
8.

Hepatitis B immunity and response to booster vaccination in children with inflammatory bowel disease treated with infliximab.

Moses J, Alkhouri N, Shannon A, Raig K, Lopez R, Danziger-Isakov L, Feldstein AE, Zein NN, Wyllie R, Carter-Kent C.

Am J Gastroenterol. 2012 Jan;107(1):133-8. doi: 10.1038/ajg.2011.295. Epub 2011 Aug 30.

PMID:
21876562
10.

Long-term immunogenicity of hepatitis B vaccination in children and adolescents in a southern Italian town.

Stroffolini T, Guadagnino V, Caroleo B, De Sarro G, Focà A, Liberto MC, Giancotti A, Barreca GS, Marascio N, Lombardo FL, Staltari O; “Sersale’s Study” Group.

Infection. 2012 Jun;40(3):299-302. doi: 10.1007/s15010-011-0233-2. Epub 2011 Dec 16.

PMID:
22173948
12.

The effects of booster vaccination of hepatitis B vaccine on anti-HBV surface antigen negative children 11-15 years after primary vaccination.

Yao J, Ren J, Shen L, Chen Y, Liang X, Cui F, Li Q, Jiang Z, Wang F.

Hum Vaccin. 2011 Oct;7(10):1055-9. doi: 10.4161/hv.7.10.15990. Epub 2011 Oct 1.

PMID:
21989290
13.

Anti-HBs responses in children vaccinated with different schedules of either plasma-derived or HBV DNA recombinant vaccine.

Da Villa G, Pelliccia MG, Peluso F, Ricciardi E, Sepe A.

Res Virol. 1997 Mar-Apr;148(2):109-14.

PMID:
9108609
14.

Impact of maternal carrier status on immunologic markers for protection after hepatitis B vaccination in infancy: a meta-analysis.

Schönberger K, Riedel C, Rückinger S, Mansmann U, Jilg W, von Kries R.

Vaccine. 2012 Sep 28;30(44):6314-26. doi: 10.1016/j.vaccine.2012.07.080. Epub 2012 Aug 8. Review.

PMID:
22885275
15.

Hepatitis B vaccination of premature infants: a reassessment of current recommendations for delayed immunization.

Losonsky GA, Wasserman SS, Stephens I, Mahoney F, Armstrong P, Gumpper K, Dulkerian S, West DJ, Gewolb IH.

Pediatrics. 1999 Feb;103(2):E14.

PMID:
9925860
16.

Comparison of a triple antigen and a single antigen recombinant vaccine for adult hepatitis B vaccination.

Young MD, Gooch WM 3rd, Zuckerman AJ, Du W, Dickson B, Maddrey WC.

J Med Virol. 2001 Jul;64(3):290-8.

PMID:
11424117
17.

Hepatitis B vaccination of adolescents: significance of non-protective antibodies.

Chiara F, Bartolucci GB, Cattai M, Piazza A, Nicolli A, Buja A, Trevisan A.

Vaccine. 2013 Dec 17;32(1):62-8. doi: 10.1016/j.vaccine.2013.10.074. Epub 2013 Nov 1.

PMID:
24188755
18.

Unexpected protection from infection by two booster hepatitis B virus vaccination in children with acute lymphoblastic leukemia.

Yetgin S, Tavil B, Aytac S, Kuskonmaz B, Kanra G.

Leuk Res. 2007 Apr;31(4):493-6. Epub 2006 Aug 23. Erratum in: Leuk Res. 2008 Nov;32(11):1791. Karna, Güler [corrected to Kanra, Güler].

PMID:
16930691
19.
20.

Anti-HBs profiles in children treated for neoplastic disease who had been vaccinated against hepatitis B postnatally or as infants.

Koltan S, Koltan A, Wysocki M, Debski R, Styczynski J.

J Hosp Infect. 2005 May;60(1):73-7.

PMID:
15823661

Supplemental Content

Support Center